CollPlant Biotechnologies Ltd (OPHI) SEC filings

OPHINasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31Also trades as CLGN

Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 26, 2026Score 9/30

Share price

Not available yet

Price, market cap and P/E appear here once daily prices are connected.

SEC filings

40 of CollPlant Biotechnologies's most recent filings on SEC EDGAR

Document	Form	Period	Filed	Source
Current report	6-K	Nov 12, 2026	Nov 12, 2026	SEC EDGAR
Current report	6-K	Nov 12, 2026	Nov 12, 2026	SEC EDGAR
Current report	6-K	Nov 5, 2026	Nov 5, 2026	SEC EDGAR
Current report	6-K	Nov 4, 2026	Nov 4, 2026	SEC EDGAR
Current report	6-K	Nov 3, 2026	Nov 3, 2026	SEC EDGAR
Current report	6-K	Nov 2, 2026	Nov 2, 2026	SEC EDGAR
Current report	6-K	Oct 29, 2026	Oct 29, 2026	SEC EDGAR
Current report	6-K	Oct 15, 2026	Oct 15, 2026	SEC EDGAR
Current report	6-K	Oct 9, 2026	Oct 9, 2026	SEC EDGAR
Current report	6-K	Oct 6, 2026	Oct 6, 2026	SEC EDGAR
Current report	6-K	Jun 30, 2026	Sep 30, 2026	SEC EDGAR
Current report	6-K	Sep 24, 2026	Sep 24, 2026	SEC EDGAR
Current report	6-K	Sep 22, 2026	Sep 22, 2026	SEC EDGAR
Current report	6-K	Sep 18, 2026	Sep 18, 2026	SEC EDGAR
Current report	6-K	Sep 4, 2026	Sep 4, 2026	SEC EDGAR
Current report	6-K	Sep 3, 2026	Sep 3, 2026	SEC EDGAR
Current report	6-K	Sep 1, 2026	Sep 1, 2026	SEC EDGAR
Current report	6-K	Aug 31, 2026	Aug 31, 2026	SEC EDGAR
Current report	6-K	Aug 18, 2026	Aug 18, 2026	SEC EDGAR
Current report	6-K	Aug 6, 2026	Aug 6, 2026	SEC EDGAR
Current report	6-K	Jul 29, 2026	Jul 29, 2026	SEC EDGAR
Current report	6-K	Jul 28, 2026	Jul 28, 2026	SEC EDGAR
Current report	6-K	Jul 7, 2026	Jul 7, 2026	SEC EDGAR
Current report	6-K	Jul 1, 2026	Jul 1, 2026	SEC EDGAR
Current report	6-K	May 29, 2026	May 29, 2026	SEC EDGAR
Current report	6-K	Apr 13, 2026	Apr 13, 2026	SEC EDGAR
Current report	6-K	Mar 26, 2026	Mar 26, 2026	SEC EDGAR
Annual report	20-F	Dec 31, 2025	Mar 26, 2026	SEC EDGAR
Current report	6-K	Mar 24, 2026	Mar 24, 2026	SEC EDGAR
Current report	6-K	Feb 26, 2026	Feb 26, 2026	SEC EDGAR
Current report	6-K	Feb 23, 2026	Feb 23, 2026	SEC EDGAR
Current report	6-K	Feb 17, 2026	Feb 17, 2026	SEC EDGAR
Current report	6-K	Feb 6, 2026	Feb 6, 2026	SEC EDGAR
Current report	6-K	Feb 5, 2026	Feb 5, 2026	SEC EDGAR
Current report	6-K	Dec 31, 2025	Dec 31, 2025	SEC EDGAR
Current report	6-K	Nov 26, 2025	Nov 26, 2025	SEC EDGAR
Current report	6-K	Nov 26, 2025	Nov 26, 2025	SEC EDGAR
Current report	6-K	Oct 27, 2025	Oct 27, 2025	SEC EDGAR
Current report	6-K	Oct 20, 2025	Oct 20, 2025	SEC EDGAR
Current report	6-K	Oct 16, 2025	Oct 16, 2025	SEC EDGAR

Where these numbers come from

Parsed from the XBRL in CollPlant Biotechnologies's annual and quarterly filings with the SEC
Per-share figures adjusted for the 1-for-10 reverse split on Sep 4, 2026
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Against peers

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is OPHI.

Compare: OPHI vs AVR · OPHI vs FEED · OPHI vs NTRB · OPHI vs HRGN · OPHI vs OSRH

Revenue growth360.4% · median -17.7%

Gross margin64.8% · median 24.3%

Operating margin-484.3% · median -946.7%

Net margin-484.6% · median -867.8%

Company	Revenue	Growth
OPHI	$2.37M	+360.4%
AVR	$2.33M	+9.0%
FEED	$1.93M	-17.7%
OSRH	$1.71M	-50.4%
NTRB	$1.62M	-37.3%
HRGN	$1.00M	+35.1%

Company

Exchange: Nasdaq
Industry: Orthopedic, Prosthetic & Surgical Appliances & Supplies
Fiscal year ends: December 31
Employees: 39
Auditor: Kost Forer Gabbay & Kasierer
SEC CIK: 1631487

Advertisement
300 × 250

See a number that looks wrong?